---
title: How I treat quantitative fibrinogen disorders
date: '2024-12-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39700501/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241220170923&v=2.18.0.post9+e462414
source: Blood
description: Quantitative fibrinogen disorders, including afibrinogenemia and hypofibrinogenemia,
  are defined by the complete absence or reduction of fibrinogen, respectively. The
  diagnosis is based on the measurement of fibrinogen activity and antigen levels,
  which define the severity of this monogenic disorder. Afibrinogenemia is the result
  of homozygosity or combined heterozygosity for the causative mutations, whereas
  monoallelic mutations lead to hypofibrinogenemia. The bleeding phenotype varies
  ...
disable_comments: true
---
Quantitative fibrinogen disorders, including afibrinogenemia and hypofibrinogenemia, are defined by the complete absence or reduction of fibrinogen, respectively. The diagnosis is based on the measurement of fibrinogen activity and antigen levels, which define the severity of this monogenic disorder. Afibrinogenemia is the result of homozygosity or combined heterozygosity for the causative mutations, whereas monoallelic mutations lead to hypofibrinogenemia. The bleeding phenotype varies ...